Related Experiment Video

Updated: May 25, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Cardiorenal Syndrome: The Clinical Cardiologists' Perspective

Eric J Chan, Kevin C Dellsperger

    Cardiorenal Medicine
    |January 20, 2012
    PubMed

    Insights

    Cardiorenal syndrome involves complex heart and kidney interactions. Understanding this relationship improves recognition, treatment, and outcomes for patients with cardiovascular disease and renal dysfunction.

    Area of Science:

    • Cardiology
    • Nephrology
    • Cardiorenal Medicine

    Background:

    • Cardiorenal syndrome describes the bidirectional communication between the heart and kidneys.
    • Cardiovascular mortality is significantly elevated in patients with renal dysfunction.
    • Evolving understanding necessitates updated recognition and treatment strategies.

    Purpose of the Study:

    • To review the key issues of cardiorenal syndrome.
    • To provide a cardiologist's perspective on cardiorenal syndrome.
    • To enhance understanding of cardiorenal syndrome pathophysiology.

    Main Methods:

    • Literature review of cardiorenal syndrome.
    • Analysis of interactions between cardiovascular and renal systems.
    • Synthesis of current knowledge from a cardiology viewpoint.

    Main Results:

    • The concept of cardiorenal syndrome has evolved significantly.
    • Improved understanding facilitates better patient recognition and treatment.
    • Pathophysiological insights are crucial for improving patient outcomes.

    Conclusions:

    • A comprehensive understanding of cardiorenal syndrome is essential.
    • Cardiologists play a vital role in managing cardiorenal syndrome.
    • Further research into cardiorenal interactions can improve patient prognosis.

    Keywords:
    Cardiorenal syndromeChronic kidney diseaseCoronary artery diseaseHeart failureMetabolic syndrome

    More Related Videos

    Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches06:51

    Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches

    Published on: September 5, 2025

    Related Concept Videos

    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

    The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...